دورية أكاديمية
أعرض في EDS

Utilization of digital tools to enhance COVID-19 and tuberculosis testing and linkage to care: A cross-sectional evaluation study among Bodaboda motorbike riders in the Nairobi Metropolis, Kenya.

التفاصيل البيبلوغرافية
العنوان: Utilization of digital tools to enhance COVID-19 and tuberculosis testing and linkage to care: A cross-sectional evaluation study among Bodaboda motorbike riders in the Nairobi Metropolis, Kenya.
المؤلفون: Karanja S; Jomo Kenyatta University of Agriculture and Technology, Juja, Kenya., Aduda J; Jomo Kenyatta University of Agriculture and Technology, Juja, Kenya., Thuo R; Jomo Kenyatta University of Agriculture and Technology, Juja, Kenya., Wamunyokoli F; Jomo Kenyatta University of Agriculture and Technology, Juja, Kenya., Oyier P; Jomo Kenyatta University of Agriculture and Technology, Juja, Kenya., Kikuvi G; Jomo Kenyatta University of Agriculture and Technology, Juja, Kenya., Kissinger H; Jomo Kenyatta University of Agriculture and Technology, Juja, Kenya., Gachohi J; Jomo Kenyatta University of Agriculture and Technology, Juja, Kenya., Mburugu P; Jomo Kenyatta University of Agriculture and Technology, Juja, Kenya., Kamau D; Jomo Kenyatta University of Agriculture and Technology, Juja, Kenya., Matheri J; Jomo Kenyatta University of Agriculture and Technology, Juja, Kenya., Mwelu S; Jomo Kenyatta University of Agriculture and Technology, Juja, Kenya., Machua J; Kenya Forestry Research Institute, Nairobi, Kenya., Amoth P; Ministry of Health Kenya, Nairobi, Kenya., Mariga D; Ministry of Health Kenya, Nairobi, Kenya., Were I; Ministry of Health Kenya, Nairobi, Kenya., Mohamed M; Department of Health Services, Nairobi Metropolitan Services, Nairobi, Kenya., Kimuyu J; Department of Health Services Machakos County, Machakos, Kenya., Saigilu S; Department of Health Services Kajiado County, Nairobi, Kenya., Wangeci R; Department of Health Services Kiambu County, Kiambu, Kenya., Mubadi K; Bodaboda Safety Association of Kenya, Nairobi, Kenya., Ndung'u J; FIND, Geneva, Switzerland., Suleiman K; FIND, Geneva, Switzerland., Kadam R; FIND, Geneva, Switzerland., Akugizibwe P; FIND, Geneva, Switzerland.
المصدر: PloS one [PLoS One] 2023 Sep 08; Vol. 18 (9), pp. e0290575. Date of Electronic Publication: 2023 Sep 08 (Print Publication: 2023).
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't
اللغة: English
بيانات الدورية: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE
أسماء مطبوعة: Original Publication: San Francisco, CA : Public Library of Science
مواضيع طبية MeSH: Off-Road Motor Vehicles* , COVID-19*/diagnosis , COVID-19*/epidemiology, Humans ; Kenya/epidemiology ; Cross-Sectional Studies ; Motorcycles
مستخلص: Kenya has registered over 300,000 cases of COVID-19 and is a high-burden tuberculosis country. Tuberculosis diagnosis was significantly disrupted by the pandemic. Access to timely diagnosis, which is key to effective management of tuberculosis and COVID-19, can be expanded and made more efficient through integrated screening. Decentralized testing at community level further increases access, especially for underserved populations, and requires robust systems for data and process management. This study delivered integrated COVID-19 and tuberculosis testing to commercial motorbike (Bodaboda) riders, a population at increased risk of both diseases with limited access to services, in four counties: Nairobi, Kiambu, Machakos and Kajiado. Testing sheds were established where riders congregate, with demand creation carried out by the Bodaboda association. Integrated symptom screening for tuberculosis and COVID-19 was conducted through a digital questionnaire which automatically flagged participants who should be tested for either, or both, diseases. Rapid antigen-detecting tests (Ag-RDTs) for COVID-19 were conducted onsite, while sputum samples were collected and transported to laboratories for tuberculosis diagnosis. End-to-end patient data were captured using digital tools. 5663 participants enrolled in the study, 4946 of whom were tested for COVID-19. Ag-RDT positivity rate was 1% but fluctuated widely across counties in line with broader regional trends. Among a subset tested by PCR, positivity was greater in individuals flagged as high risk by the digital tool (8% compared with 4% overall). Of 355 participants tested for tuberculosis, 7 were positive, with the resulting prevalence rate higher than the national average. Over 40% of riders had elevated blood pressure or abnormal sugar levels. The digital tool successfully captured complete end-to-end data for 95% of all participants. This study revealed high rates of undetected disease among Bodaboda riders and demonstrated that integrated diagnosis can be delivered effectively in communities, with the support of digital tools, to maximize access.
Competing Interests: J.N., K.S., R.K., and P.A. declare that they are employed by FIND. The other authors have declared that no competing interests exist.
(Copyright: © 2023 Karanja et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.)
References: PLoS One. 2018 Dec 26;13(12):e0209098. (PMID: 30586448)
Trop Med Infect Dis. 2021 May 10;6(2):. (PMID: 34068615)
Cochrane Database Syst Rev. 2021 Mar 24;3:CD013705. (PMID: 33760236)
Int J Infect Dis. 2020 Jul;96:648-654. (PMID: 32497806)
Malar J. 2019 Feb 21;18(1):45. (PMID: 30791909)
Nat Med. 2020 Aug;26(8):1183-1192. (PMID: 32770165)
medRxiv. 2022 Feb 28;:. (PMID: 35262086)
JMIR Form Res. 2022 Feb 24;6(2):e27501. (PMID: 35200151)
BMJ Open. 2021 Mar 3;11(3):e042749. (PMID: 33658260)
Diagnostics (Basel). 2022 Feb 03;12(2):. (PMID: 35204493)
JMIR Mhealth Uhealth. 2020 Apr 21;8(4):e17246. (PMID: 32314977)
Lancet. 2022 Apr 16;399(10334):1513-1536. (PMID: 35279232)
Lancet Glob Health. 2022 Apr;10(4):e465-e466. (PMID: 35122718)
J Med Internet Res. 2020 Feb 13;22(2):e15727. (PMID: 32053111)
Eur Respir J. 2022 Mar 24;59(3):. (PMID: 34764184)
PLoS Med. 2021 Aug 12;18(8):e1003735. (PMID: 34383750)
تواريخ الأحداث: Date Created: 20230908 Date Completed: 20230911 Latest Revision: 20231102
رمز التحديث: 20231102
مُعرف محوري في PubMed: PMC10490987
DOI: 10.1371/journal.pone.0290575
PMID: 37682928
قاعدة البيانات: MEDLINE
الوصف
تدمد:1932-6203
DOI:10.1371/journal.pone.0290575